Researchers have been excited about this new drug, a novel dual treatment showing significant data in initial trials for size reduction . It acts by targeting several hormones : GLP-1 and GIP, these, when engaged , support influence cravings and enhance energy expenditure . Preliminary findings suggest substantial body reduction and likely improvem